MedPath

SRX-246

Generic Name
SRX-246
Drug Type
Small Molecule
Chemical Formula
C42H49N5O5
CAS Number
512784-93-9
Unique Ingredient Identifier
372X2P22UY

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans
Phase 1
Posted: 2016/10/04
Sponsor:
Azevan Pharmaceutica...
ID:NCT02922166
Proof-of-concept Study to Assess the Efficacy and Safety of SRX246 in Adults With PTSD
Phase 2
Terminated
Posted: 2016/04/11
Sponsor:
Azevan Pharmaceutica...
ID:NCT02733614
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Phase 2
Completed
Posted: 2015/07/23
Sponsor:
Azevan Pharmaceutica...
ID:NCT02507284
Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder
Phase 1
Completed
Posted: 2014/02/05
Sponsor:
Azevan Pharmaceutica...
ID:NCT02055638
Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers
Phase 1
Completed
Posted: 2010/03/18
Sponsor:
Azevan Pharmaceutica...
ID:NCT01088932

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy